In silico prediction of the neutralization range of human anti-HIV monoclonal antibodies
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1742-4690
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
In silico prediction of the neutralization range of human anti-HIV monoclonal antibodies ; volume:9 ; number:2 ; day:13 ; month:9 ; year:2012 ; pages:1 ; date:9.2012
Retrovirology ; 9, Heft 2 (13.9.2012), 1, 9.2012
- Urheber
-
Shmelkov, E.
- Beteiligte Personen und Organisationen
-
Krachmarov, C.
Grigoryan, A.
Agarwal, A.
Statnikov, A.
Cardozo, T.
SpringerLink (Online service)
- DOI
-
10.1186/1742-4690-9-S2-P332
- URN
-
urn:nbn:de:1111-2016080727766
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:56 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Shmelkov, E.
- Krachmarov, C.
- Grigoryan, A.
- Agarwal, A.
- Statnikov, A.
- Cardozo, T.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Monoclonal antibodies
Characterization of human anti-HIV-1 Env-specific monoclonal antibodies in vitro and in vivo
Characterization of human anti-HIV-1 Env-specific monoclonal antibodies in vitro and in vivo
Reduced neutralization of SARS-CoV-2 Omicron variant by vaccine sera and monoclonal antibodies
Reduced neutralization of SARS-CoV-2 Omicron variant by vaccine sera and monoclonal antibodies
Augmented neutralization of SARS‐CoV‐2 Omicron variant by boost vaccination and monoclonal antibodies
SHIVs, monkeys, and anti-HIV-1 neutralizing antibodies
P04-10. Neutralization of Tier 1 and Tier 2 pseudoviruses by human anti-V3 monoclonal antibodies
Monoclonal antibodies in transplantation
Glycoengineering of Monoclonal Antibodies
A universal in silico V(D)J recombination strategy for developing humanized monoclonal antibodies
Administration of anti-HIV-1 broadly neutralizing monoclonal antibodies with increased affinity to Fcγ receptors during acute SHIVAD8-EO infection
Monoclonal antibodies
Characterization of human anti-HIV-1 Env-specific monoclonal antibodies in vitro and in vivo
Characterization of human anti-HIV-1 Env-specific monoclonal antibodies in vitro and in vivo
Reduced neutralization of SARS-CoV-2 Omicron variant by vaccine sera and monoclonal antibodies
Reduced neutralization of SARS-CoV-2 Omicron variant by vaccine sera and monoclonal antibodies
Augmented neutralization of SARS‐CoV‐2 Omicron variant by boost vaccination and monoclonal antibodies
SHIVs, monkeys, and anti-HIV-1 neutralizing antibodies
P04-10. Neutralization of Tier 1 and Tier 2 pseudoviruses by human anti-V3 monoclonal antibodies
Monoclonal antibodies in transplantation
Glycoengineering of Monoclonal Antibodies
A universal in silico V(D)J recombination strategy for developing humanized monoclonal antibodies
Administration of anti-HIV-1 broadly neutralizing monoclonal antibodies with increased affinity to Fcγ receptors during acute SHIVAD8-EO infection
Monoclonal antibodies
Characterization of human anti-HIV-1 Env-specific monoclonal antibodies in vitro and in vivo
Characterization of human anti-HIV-1 Env-specific monoclonal antibodies in vitro and in vivo
Reduced neutralization of SARS-CoV-2 Omicron variant by vaccine sera and monoclonal antibodies
Reduced neutralization of SARS-CoV-2 Omicron variant by vaccine sera and monoclonal antibodies
Augmented neutralization of SARS‐CoV‐2 Omicron variant by boost vaccination and monoclonal antibodies
SHIVs, monkeys, and anti-HIV-1 neutralizing antibodies
P04-10. Neutralization of Tier 1 and Tier 2 pseudoviruses by human anti-V3 monoclonal antibodies
Monoclonal antibodies in transplantation
Glycoengineering of Monoclonal Antibodies
A universal in silico V(D)J recombination strategy for developing humanized monoclonal antibodies